https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-01 / Int J Hyperthermia 2008 Dec;24(8):649-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-01 / Int J Hyperthermia 2008 Dec;24(8):649-622008-12-01 00:00:002019-02-15 09:17:39Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-09-27 / Surg. Today 2008;38(10):911-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-09-27 / Surg. Today 2008;38(10):911-202008-09-27 00:00:002008-09-27 00:00:00Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-408
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / Int J Hyperthermia 2008 Aug;24(5):399-4082008-08-01 00:00:002008-08-01 00:00:00Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-08-01 / J Biomech Eng 2008 Aug;130(4):041016
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-08-01 / J Biomech Eng 2008 Aug;130(4):0410162008-08-01 00:00:002019-02-15 10:00:35A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-11 / Cancer Immunol. Immunother. 2009 Mar;58(3):361-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-11 / Cancer Immunol. Immunother. 2009 Mar;58(3):361-712008-07-11 00:00:002008-07-11 00:00:00TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-01 / Curr Opin Oncol 2008 Jul;20(4):438-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-01 / Curr Opin Oncol 2008 Jul;20(4):438-432008-07-01 00:00:002008-07-01 00:00:00Regional hyperthermia in high-risk soft tissue sarcomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-04-24 / Vaccine 2008 Jun;26(27-28):3540-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-04-24 / Vaccine 2008 Jun;26(27-28):3540-92008-04-24 00:00:002019-02-15 08:49:58Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-03-01 / Int J Hyperthermia 2008 Mar;24(2):171-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-03-01 / Int J Hyperthermia 2008 Mar;24(2):171-812008-03-01 00:00:002008-03-01 00:00:00The importance of schedule in whole body thermochemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):41-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):41-562008-02-01 00:00:002019-02-15 09:17:41Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):67-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):67-782008-02-01 00:00:002019-02-15 09:17:40Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress
